# Study on the Efficacy and Safety of Ultrasound-Guided Peritendinous Injection of Low-Molecular-Weight Hyaluronic Acid (Hyalotend®; 500-730 kDa) for Chronic Non-Calcific Supraspinatus Tendinopathy.

> **NCT07699406** · — · NOT_YET_RECRUITING · sponsor: **University Hospital of the Nuestra Señora de Candelaria** · enrollment: 30 (estimated)

## Conditions studied

- Supraespinatus Tendinopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07699406
- **Lead sponsor:** University Hospital of the Nuestra Señora de Candelaria
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07699406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07699406, "Study on the Efficacy and Safety of Ultrasound-Guided Peritendinous Injection of Low-Molecular-Weight Hyaluronic Acid (Hyalotend®; 500-730 kDa) for Chronic Non-Calcific Supraspinatus Tendinopathy.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07699406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*